ISPOR 2016 EU – Value Added Medicines

18 November 2016

Policy, Report

Healthcare System Inefficiencies Related To Medicines: Any Potential Room For […]

Market Review – European Generic Medicines Markets 2016

10 November 2016

Report

Simon-Kucher. Policy Requirements for a Sustainable Biosimilar Market (September 2016)

19 September 2016

Report

IMS – The Impact of Biosimilar Competition (2016)

1 June 2016

Report

Value Added Medicines: Rethink, Reinvent & Optimize Medicines, Improving Patient Health & Access

31 May 2016

Policy, Report

IMS Institute – Biosimilar Report

31 March 2016

Report

IMS – The Impact of Biosimilar Competition (2015)

1 November 2015

Report

This document sets out to describe the effects on price, […]

IGES Report: Value of Generic Medicines – Health Economics Study, Berlin, 5 October 2015

5 October 2015

Report

To consult the infographics, please click here.

EGA Vision 2015

19 July 2015

Report

To view the full report, please click here.

IMS Health 2015: The Role of Generic Medicines in Sustaining Healthcare Systems: A European Perspective, June 2015

1 June 2015

Report

To view the full report, click here To view the […]